Related Articles
Dihydroartemisinin inhibits vascular endothelial growth factor‑induced endothelial cell migration by a p38 mitogen‑activated protein kinase‑independent pathway
Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells